SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
05-Sep-24 6:00 AM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 03-Sep-24 | Option Sale | 431 | $204.22 | $88,018.80 | (7%) 5.75K to 5.32K | |
05-Sep-24 6:00 AM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 30-Aug-24 | Payment of Exercise | 807 | $204.76 | $165,241.00 | (12%) 6.55K to 5.75K | |
05-Sep-24 6:00 AM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 30-Aug-24 | Option Exercise | 1,668 | -- | -- | 34% 4.89K to 6.55K | |
25-Jun-24 5:14 PM View: | Hawkins William A Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 26% 5.15K to 6.49K | |
25-Jun-24 5:06 PM View: | Dorsa Caroline Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,785 | -- | -- | 7% 24.82K to 26.61K | |
25-Jun-24 5:16 PM View: | Langer Susan Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 94% 1.42K to 2.76K | |
25-Jun-24 5:19 PM View: | Mantas Jesus B Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 22% 6.05K to 7.39K | |
25-Jun-24 5:18 PM View: | Rowinsky Eric K Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 6% 20.63K to 21.97K | |
25-Jun-24 5:13 PM View: | Freire Maria C Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 43% 3.1K to 4.45K | |
25-Jun-24 5:15 PM View: | Patolawala Monish D Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 100% 0 to 1.34K | |
25-Jun-24 5:20 PM View: | Sherwin Stephen A Director | Biogen Idec Inc. (BIIB) | 21-Jun-24 | Grant | 1,340 | -- | -- | 7% 18.74K to 20.08K | |
03-May-24 8:00 PM View: | Keeney Adam Head of Corporate Development | Biogen Idec Inc. (BIIB) | 01-May-24 | Payment of Exercise | 276 | $216.13 | $59,651.90 | (29%) 0.94K to 0.66K | |
03-May-24 8:00 PM View: | Keeney Adam Head of Corporate Development | Biogen Idec Inc. (BIIB) | 01-May-24 | Option Exercise | 938 | -- | -- | 100% 0 to 0.94K | |
03-Apr-24 8:24 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 02-Apr-24 | Sale | 93 | $213.09 | $19,817.40 | (2%) 4.98K to 4.89K | |
03-Apr-24 8:11 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 01-Apr-24 | Payment of Exercise | 117 | $214.83 | $25,135.10 | (1%) 9.75K to 9.63K | |
03-Apr-24 8:11 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 01-Apr-24 | Option Exercise | 240 | -- | -- | 3% 9.51K to 9.75K | |
26-Feb-24 7:54 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 22-Feb-24 | Sale | 262 | $221.23 | $57,962.30 | (5%) 5.15K to 4.89K | |
21-Feb-24 9:31 PM View: | Kramer Robin Chief Accounting Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 396 | $219.08 | $86,755.70 | (6%) 6.62K to 6.23K | |
21-Feb-24 9:33 PM View: | Izzar Rachid Head of Global Product Strat. | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 952 | $219.08 | $208,564.00 | (9%) 10.65K to 9.7K | |
21-Feb-24 9:33 PM View: | Izzar Rachid Head of Global Product Strat. | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 2,017 | -- | -- | 23% 8.64K to 10.65K | |
21-Feb-24 9:36 PM View: | Gregory Ginger EVP, Human Resources | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 2,264 | $219.08 | $495,997.00 | (14%) 15.85K to 13.58K | |
21-Feb-24 9:36 PM View: | Gregory Ginger EVP, Human Resources | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 4,704 | -- | -- | 42% 11.14K to 15.85K | |
21-Feb-24 9:28 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 610 | $219.08 | $133,639.00 | (6%) 10.03K to 9.42K | |
21-Feb-24 9:27 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Sale | 108 | $221.49 | $23,920.90 | (2%) 5.26K to 5.15K | |
21-Feb-24 9:31 PM View: | Kramer Robin Chief Accounting Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 1,345 | -- | -- | 25% 5.28K to 6.62K | |
21-Feb-24 9:29 PM View: | McDonnell Michael R EVP, Chief Financial Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 3,438 | $219.08 | $753,197.00 | (15%) 22.84K to 19.41K | |
21-Feb-24 9:29 PM View: | McDonnell Michael R EVP, Chief Financial Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 6,720 | -- | -- | 42% 16.12K to 22.84K | |
21-Feb-24 9:27 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 468 | $219.08 | $102,529.00 | (8%) 5.72K to 5.26K | |
21-Feb-24 9:28 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 1,260 | -- | -- | 14% 8.77K to 10.03K | |
21-Feb-24 9:39 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Payment of Exercise | 2,437 | $219.08 | $533,898.00 | (5%) 54.12K to 51.68K | |
21-Feb-24 9:27 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 1,208 | -- | -- | 27% 4.52K to 5.72K | |
21-Feb-24 9:39 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 16-Feb-24 | Option Exercise | 5,037 | -- | -- | 10% 49.08K to 54.12K | |
20-Feb-24 9:13 PM View: | Rowinsky Eric K Director | Biogen Idec Inc. (BIIB) | 15-Feb-24 | Private Purchase | 455 | $222.54 | $101,256.00 | 2% 20.17K to 20.63K | |
13-Feb-24 6:06 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 12-Feb-24 | Option Sale | 419 | $239.45 | $100,330.00 | (8%) 4.93K to 4.52K | |
13-Feb-24 6:01 PM View: | Kramer Robin Chief Accounting Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 833 | -- | -- | 18% 4.69K to 5.52K | |
13-Feb-24 6:03 PM View: | McDonnell Michael R EVP, Chief Financial Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 1,431 | $240.98 | $344,842.00 | (8%) 17.55K to 16.12K | |
13-Feb-24 6:03 PM View: | McDonnell Michael R EVP, Chief Financial Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 3,257 | -- | -- | 23% 14.3K to 17.55K | |
13-Feb-24 6:06 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 374 | $240.98 | $90,126.50 | (7%) 5.31K to 4.93K | |
13-Feb-24 6:04 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 2,272 | -- | -- | 31% 7.26K to 9.53K | |
13-Feb-24 5:56 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 938 | $240.98 | $226,039.00 | (2%) 50.02K to 49.08K | |
13-Feb-24 6:06 PM View: | Singhal Priya Head of Development | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 1,212 | -- | -- | 30% 4.1K to 5.31K | |
13-Feb-24 5:56 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 2,575 | -- | -- | 5% 47.45K to 50.02K | |
13-Feb-24 6:01 PM View: | Kramer Robin Chief Accounting Officer | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 245 | $240.98 | $59,040.10 | (4%) 5.52K to 5.28K | |
13-Feb-24 6:00 PM View: | Izzar Rachid Head of Global Product Strat. | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 445 | $240.98 | $107,236.00 | (5%) 9.08K to 8.64K | |
13-Feb-24 6:00 PM View: | Izzar Rachid Head of Global Product Strat. | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 1,515 | -- | -- | 20% 7.57K to 9.08K | |
13-Feb-24 6:14 PM View: | Gregory Ginger EVP, Human Resources | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 634 | $240.98 | $152,781.00 | (5%) 11.78K to 11.14K | |
13-Feb-24 6:14 PM View: | Gregory Ginger EVP, Human Resources | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Option Exercise | 2,158 | -- | -- | 22% 9.62K to 11.78K | |
13-Feb-24 6:04 PM View: | Murphy Nicole Head of Pharm Ops and Tech | Biogen Idec Inc. (BIIB) | 09-Feb-24 | Payment of Exercise | 761 | $240.98 | $183,386.00 | (8%) 9.53K to 8.77K | |
09-Feb-24 8:16 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 08-Feb-24 | Payment of Exercise | 655 | $240.30 | $157,396.00 | (1%) 48.1K to 47.45K | |
09-Feb-24 8:16 PM View: | Alexander Susan H EVP Chief Legal Officer | Biogen Idec Inc. (BIIB) | 08-Feb-24 | Option Exercise | 2,190 | -- | -- | 5% 45.91K to 48.1K |